Brief: First Wave Biopharma Engages Rho To Manage Phase 2 Clinical Trial Of Enhanced Adrulipase Formulation

GridAI Technologies

31/10/2022 11:37

Oct 31 (Reuters) - First Wave BioPharma Inc  FWBI.O :
    * FIRST WAVE BIOPHARMA ENGAGES RHO TO MANAGE PHASE 2
CLINICAL
TRIAL OF ENHANCED ADRULIPASE FORMULATION
    * FIRST WAVE BIOPHARMA INC - PHASE 2 CLINICAL TRIAL IS
EXPECTED TO
INITIATE PRIOR TO CLOSE OF 2022
    * FIRST WAVE BIOPHARMA INC - UNDER AGREEMENT, RHO WILL
MANAGE
PHASE 2 CLINICAL TRIAL OF MICROGRANULE DRUG DELIVERY FORMULATION
OF ADRULIPASE

Source text for Eikon:  ID:nGNX9vztvM 
Further company coverage:  FWBI.O 
 ((Reuters.Briefs@thomsonreuters.com;))